PharmaLex Nordic regional hub at your service

PharmaLex Denmark, PharmaLex Finland, PharmaLex Norway and PharmaLex Sweden have joined forces and become a Nordic region powerhouse serving pharma, medtech and biotech companies locally and globally.    

From this regional hub you get comprehensive services throughout the Nordic region handling marketing authorisations, registrations and launches in all the Nordic countries. We are also committed to building bridges for local companies to global markets.    

Together we can achieve a stronger presence in the Nordic countries giving our clients access to broader expertise in multiple markets”, said Nordic Region Head Torben Thers Nørgaard

PharmaLex is a leading provider of specialised services for the pharma, biotech and medical device industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.  

The PharmaLex Group has over 3000 employees with 60+ offices in 32 countries and more than 1,600 satisfies clients worldwide.  

PharmaLex is now part of AmerisourceBergen, a leading global healthcare company with a foundation in pharmaceutical distribution.  


This blog is intended to communicate PharmaLex’s capabilities which are backed by the author’s expertise. However, PharmaLex US Corporation and its parent, Cencora, Inc., strongly encourage readers to review the references provided with this article and all available information related to the topics mentioned herein and to rely on their own experience and expertise in making decisions related thereto as the article may contain certain marketing statements and does not constitute legal advice. 

Contact us for more information

Scroll to Top